Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
White mineral trioxide aggregate + sodium hypochlorite gel (WMTA + NaOCl gel) is an experimental dental material developed by researchers at Damascus University for use in pediatric endodontics. It consists of white mineral trioxide aggregate (WMTA), a biocompatible dental cement, mixed with a 2.25% sodium hypochlorite (NaOCl) gel vehicle instead of distilled water. This formulation is designed to improve the handling properties and setting time of WMTA while enhancing its antimicrobial activity. It is primarily investigated as a pulpotomy medicament for primary molars in children with dental caries, aiming to promote pulp healing and maintain tooth vitality through its biocompatible and antibacterial properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on white mineral trioxide aggregate + sodium hypochlorite gel.